BioPharm Asia Opens 360 Chain Drugstores In Northeast China
This article was originally published in PharmAsia News
Tonghua ShengAnTang Medicine Chain, a subsidiary of BioPharm Asia, recently opened 360 chain drugstores in Jilin and Liaoning provinces. The activity shows the company's next move is to improve and rapidly expand its network of chain drugstores through large-scale acquisitions. Industry analysts point out that with the continuous push of China's healthcare reform, improvement in new rural cooperative medical care systems and rising rural incomes, existing chain drugstores in central cities will seek growth opportunities in small towns and populous villages. (Click here for more - Chinese Language)
You may also be interested in...
Mylan and Pfizer’s Upjohn, already facing a delay to their proposed merger, may have to overcome regulatory barriers to get the deal over the line.
National export restrictions on medicines have been slammed by the international off-patent pharmaceutical industry as being “counter-productive” during the coronavirus crisis. The IGBA is instead urging international co-operation and transparency, pointing to a positive example of supply-chain connectivity in the Asia-Pacific region.
Claims circulated on social media that its Cebion supplement could prevent coronavirus has led Italy's Dompé to take legal action.